Menu

Planep适合什么人用?

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

Planep (alias: Inspra) is a new type of selective aldosterone receptor antagonist. Who is Planep suitable for?

Indications of Planep:

1. Congestive heart failure after acute myocardial infarction: Planep can improve the quality of life of patients with left ventricular dysfunction (ejection fraction ≤ 40%). Clinical trials have proven that Planep can also be used for congestive heart failure after acute myocardial infarction;

2. Anti-hypertensive: Planep can be used alone or in combination with other anti-hypertensive drugs for the treatment of hypertension.

Planep has few adverse reactions and is effective in treating hypertension, heart failure and myocardial infarction. It has fewer adverse reactions and is well tolerated. It is a good alternative to spironolactone!

Planep can be used alone or in combination with other antihypertensive drugs. The recommended dose is 50 mg per day. If the blood pressure lowering effect is not satisfactory after 4 weeks, the dose can be adjusted to 100 mg per day.

Planep is a selective aldosterone protein kinase antagonist that only acts on mineralocorticoid protein kinase and has no effect on androgen and progesterone protein kinases.

Planep treats patients with stage 1 and stage 2 hypertension with high efficiency and similar potency in reducing diastolic blood pressure and systolic blood pressure as enalapril. Planep also has a good blood pressure lowering effect in patients with essential hypertension with low renin levels for whom angiotensin 2-converting enzyme inhibitors and angiotensin 2Ⅱ protein kinase inhibitors are not effective. It also has a good blood pressure lowering effect on simple systolic hypertension, and has a good blood pressure lowering effect on obesity-related hypertension caused by diet.

In addition, Planep can significantly reduce the ultrafiltration membrane function of renal tubules and alleviate albuminuria in patients with hypertension. For patients with hypertension combined with diabetes, this renal function protection effect is even more significant.

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。